Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarction
- 1 August 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (3) , 261-266
- https://doi.org/10.1016/0002-9149(90)90832-l
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarctionThe American Journal of Cardiology, 1988
- Ventricular function and infarct size: The Western Washington Intravenous Streptokinase in Myocardial Infarction TrialJournal of the American College of Cardiology, 1988
- Early intervention in acute myocardial infarction: Significance for myocardial salvage of immediate intravenous streptokinase therapy followed by coronary angioplastyJournal of the American College of Cardiology, 1987
- Reversible ischemic left ventricular dysfunction: Evidence for the “hibernating myocardium”Journal of the American College of Cardiology, 1986
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- Prevention of Myocardial Damage in Acute Myocardial Ischemia by Early Treatment with Intravenous StreptokinaseNew England Journal of Medicine, 1985
- Time from onset of symptoms to thrombolytic therapy: A major determinant of myocardial salvage in patients with acute transmural infarctionJournal of the American College of Cardiology, 1985
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Sustained improvement in left ventricular function and mortality by intracoronary streptokinase administration during evolving myocardial infarction.Circulation, 1983